Related Experiment Videos
Flow-mediated dilatation
O T Raitakari1, D S Celermajer
1Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
British Journal of Clinical Pharmacology
|November 9, 2000
Summary
Arterial endothelial dysfunction, a key event in atherosclerosis, can now be assessed noninvasively. This ultrasound method measures arterial changes, correlating with invasive tests and offering insights into reversibility.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Diagnostic Imaging
Background:
- Arterial endothelial dysfunction is a crucial early event in atherogenesis, preceding structural changes and contributing to obstructive atherosclerosis.
- Traditional methods for measuring endothelial function are invasive, limiting their use in asymptomatic individuals.
- The development of noninvasive tests is essential for studying endothelial function in broader populations.
Purpose of the Study:
- To evaluate the utility of noninvasive ultrasound-based testing for assessing arterial endothelial function.
- To compare noninvasive findings with invasive measurements and coronary atherosclerosis severity.
- To explore the potential for reversing endothelial dysfunction using various therapeutic strategies.
Main Methods:
- Utilized an ultrasound-based method to measure arterial diameter changes in response to increased shear stress.
- Assessed endothelium-dependent dilatation, a marker of endothelial function.
- Correlated noninvasive endothelial function measurements with invasive testing and coronary atherosclerosis extent.
Main Results:
- Noninvasive endothelial function testing demonstrated correlation with invasive coronary endothelial function assessments.
- The method showed correlation with the severity and extent of coronary atherosclerosis.
- This approach provided insights into the reversibility of endothelial dysfunction.
Conclusions:
- Noninvasive ultrasound assessment of endothelial function is a valuable tool for studying early atherogenesis.
- This method offers a viable alternative to invasive testing, particularly for asymptomatic subjects.
- Findings support the potential reversibility of endothelial dysfunction through pharmacological and other interventions.